Considering the role of IL-13Rα2 in cancer progression [16,33] and the effectiveness of blocking IL-13Rα2-related pathways in inhibiting and deteriorating cancer cells [33,34], IL-13Rα2 might be a potential therapeutic target for osteosarcoma. Here, IL13RA2 is linked to osteosarcoma.